Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908-1337, USA.
Am J Trop Med Hyg. 2012 Jun;86(6):980-1. doi: 10.4269/ajtmh.2012.11-0661.
Amebiasis is a major cause of morbidity and mortality in the developing world. A reliable point-of-care test would help to improve diagnosis and early treatment. We evaluated a novel rapid fecal antigen detection test for E. histolytica (E. HISTOLYTICA QUIK CHEK; TechLab, Inc., Blacksburg, VA), in a cohort of children in Bangladesh where amebiasis is endemic. This point-of-care test had a sensitivity of 100% and a specificity of 100% when compared with enzyme-linked immunosorbent assay antigen detection.
阿米巴病是发展中国家发病率和死亡率的主要原因。一种可靠的即时检测方法将有助于改善诊断和早期治疗。我们在孟加拉国的一个阿米巴病流行的儿童队列中评估了一种新的快速粪便抗原检测技术（TechLab，弗吉尼亚州布莱克斯堡的 E. histolytica [E. HISTOLYTICA QUIK CHEK]）。与酶联免疫吸附试验抗原检测相比，该即时检测方法的敏感性为 100%，特异性为 100%。
